These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 10928298)

  • 1. Nitric oxide--angiotensin II axis in renal and cardiovascular injury.
    Adam A; Raij L
    J Nephrol; 2000; 13(3):211-20. PubMed ID: 10928298
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The pathophysiologic basis for blocking the renin-angiotensin system in hypertensive patients with renal disease.
    Raij L
    Am J Hypertens; 2005 Apr; 18(4 Pt 2):95S-99S. PubMed ID: 15837551
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interaction between nitric oxide and angiotensin II in the endothelium: role in atherosclerosis and hypertension.
    Schulman IH; Zhou MS; Raij L
    J Hypertens Suppl; 2006 Mar; 24(1):S45-50. PubMed ID: 16601573
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of renin-angiotensin system inhibition on end-organ protection: can we do better?
    Weir MR
    Clin Ther; 2007 Sep; 29(9):1803-24. PubMed ID: 18035185
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activation of ATP-sensitive potassium channels protects vascular endothelial cells from hypertension and renal injury induced by hyperuricemia.
    Long CL; Qin XC; Pan ZY; Chen K; Zhang YF; Cui WY; Liu GS; Wang H
    J Hypertens; 2008 Dec; 26(12):2326-38. PubMed ID: 19008712
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gender differences in the renin-angiotensin and nitric oxide systems: relevance in the normal and diseased kidney.
    McGuire BB; Watson RW; Pérez-Barriocanal F; Fitzpatrick JM; Docherty NG
    Kidney Blood Press Res; 2007; 30(2):67-80. PubMed ID: 17268203
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nitric oxide synthase inhibition accelerates the pressor response to low-dose angiotensin II, exacerbates target organ damage, and induces renin escape.
    Hu L; Sealey JE; Chen R; Zhou Y; Merali C; Shi Y; Laragh JH; Catanzaro DF
    Am J Hypertens; 2004 May; 17(5 Pt 1):395-403. PubMed ID: 15110897
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tonic levels of angiotensin II reduce tonic levels of vascular nitric oxide even in salt-replete man.
    Sim JS; Farquharson C; Struthers AD
    J Renin Angiotensin Aldosterone Syst; 2004 Jun; 5(2):84-8. PubMed ID: 15295720
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanisms of progressive renal disease: role of angiotensin II, cyclooxygenase products and nitric oxide.
    Zatz R; Fujihara CK
    J Hypertens Suppl; 2002 Jun; 20(3):S37-44. PubMed ID: 12184054
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of the renin-angiotensin-aldosterone system in cardiovascular progenitor cell function.
    Qian C; Schoemaker RG; van Gilst WH; Roks AJ
    Clin Sci (Lond); 2009 Feb; 116(4):301-14. PubMed ID: 19138171
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Calcium channel blockers, endothelial dysfunction, and combination therapy.
    Schulman IH; Zachariah M; Raij L
    Aging Clin Exp Res; 2005 Aug; 17(4 Suppl):40-5. PubMed ID: 16640172
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endothelin, renal diseases, and hypertension.
    Dussaule JC; Boffa JJ; Tharaux PL; Fakhouri F; Ardaillou R; Chatziantoniou C
    Adv Nephrol Necker Hosp; 2000; 30():281-303. PubMed ID: 11068648
    [No Abstract]   [Full Text] [Related]  

  • 13. [The role of the selective blocking of angiotensin II receptors in the treatment of cardiovascular diseases].
    Carnovali M
    Clin Ter; 2001; 152(2):103-6. PubMed ID: 11441521
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The role of neurohormonal mechanisms in the etiopathogenesis of essential hypertension].
    Zyśko D; Przewłocka-Kosmala M
    Pol Merkur Lekarski; 1998 Sep; 5(27):157-61. PubMed ID: 10101486
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Inhibition of the renin-angiotensin system to prevent target organ damage: the "renal continuum"].
    Tislér A
    Orv Hetil; 2003 May; 144(18 Suppl 1):898-901. PubMed ID: 12785234
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Benazepril, an angiotensin-converting enzyme inhibitor, alleviates renal injury in spontaneously hypertensive rats by inhibiting advanced glycation end-product-mediated pathways.
    Liu XP; Pang YJ; Zhu WW; Zhao TT; Zheng M; Wang YB; Sun ZJ; Sun SJ
    Clin Exp Pharmacol Physiol; 2009 Mar; 36(3):287-96. PubMed ID: 19018797
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Simvastatin and losartan enhance nitric oxide and reduce oxidative stress in salt-induced hypertension.
    Bayorh MA; Ganafa AA; Eatman D; Walton M; Feuerstein GZ
    Am J Hypertens; 2005 Nov; 18(11):1496-502. PubMed ID: 16280288
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Kidney angiotensin receptors and their role in renal pathophysiology.
    Sandberg K; Ji H
    Semin Nephrol; 2000 Sep; 20(5):402-16. PubMed ID: 11022892
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nitric oxide, angiotensin II, and hypertension.
    Zhou MS; Schulman IH; Raij L
    Semin Nephrol; 2004 Jul; 24(4):366-78. PubMed ID: 15252776
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interaction of endothelial nitric oxide and angiotensin in the circulation.
    Toda N; Ayajiki K; Okamura T
    Pharmacol Rev; 2007 Mar; 59(1):54-87. PubMed ID: 17329548
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.